DK333183A - Fremgangsmaade til fremstilling af herpes simplex virusglycoproteiner - Google Patents

Fremgangsmaade til fremstilling af herpes simplex virusglycoproteiner Download PDF

Info

Publication number
DK333183A
DK333183A DK333183A DK333183A DK333183A DK 333183 A DK333183 A DK 333183A DK 333183 A DK333183 A DK 333183A DK 333183 A DK333183 A DK 333183A DK 333183 A DK333183 A DK 333183A
Authority
DK
Denmark
Prior art keywords
procedure
preparation
herpes simplex
simplex virus
virus glycoproteins
Prior art date
Application number
DK333183A
Other languages
English (en)
Other versions
DK333183D0 (da
Inventor
Roger John Watson
John Haynes Weis
Lynn William Enquist
Original Assignee
Molecular Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27410368&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK333183(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US06/400,028 external-priority patent/US4818694A/en
Priority claimed from US06/510,551 external-priority patent/US4891315A/en
Application filed by Molecular Genetics Inc filed Critical Molecular Genetics Inc
Publication of DK333183D0 publication Critical patent/DK333183D0/da
Publication of DK333183A publication Critical patent/DK333183A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK333183A 1982-07-20 1983-07-19 Fremgangsmaade til fremstilling af herpes simplex virusglycoproteiner DK333183A (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/400,028 US4818694A (en) 1982-07-20 1982-07-20 Production of herpes simplex viral protein
US43636882A 1982-10-25 1982-10-25
US06/510,551 US4891315A (en) 1982-10-25 1983-07-06 Production of herpes simplex viral porteins

Publications (2)

Publication Number Publication Date
DK333183D0 DK333183D0 (da) 1983-07-19
DK333183A true DK333183A (da) 1984-01-21

Family

ID=27410368

Family Applications (1)

Application Number Title Priority Date Filing Date
DK333183A DK333183A (da) 1982-07-20 1983-07-19 Fremgangsmaade til fremstilling af herpes simplex virusglycoproteiner

Country Status (14)

Country Link
EP (1) EP0101655B1 (da)
CA (1) CA1295561C (da)
DE (1) DE3382072D1 (da)
DK (1) DK333183A (da)
ES (2) ES8504254A1 (da)
FI (1) FI83974C (da)
GR (1) GR78647B (da)
IE (1) IE56902B1 (da)
IL (1) IL69269A (da)
NO (1) NO172855C (da)
NZ (1) NZ204948A (da)
PH (1) PH21239A (da)
PL (1) PL150654B1 (da)
PT (1) PT77014B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3228501A1 (de) * 1982-07-30 1984-02-02 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung eines herpes-antigens, dazu geeignetes mittel sowie verfahren zu seiner herstellung und die verwendung dieses antigens
DK305784A (da) * 1983-06-23 1984-12-24 Stanley Person Ikke-glycosyleret aminosyrekaede af glycoprotein b fra herpes virus type 1 og 2
NZ209307A (en) * 1983-08-30 1990-07-26 Genentech Inc Diagnostic product: antigenic peptide produced by recombinant dna techniques
US7264817B1 (en) 1983-08-30 2007-09-04 Genentech, Inc. Immunogenic composition based on a truncated derivative of a membrane bound protein and process for making it
NZ209308A (en) * 1983-08-30 1991-08-27 Genentech Inc Vaccine against hsv involving a truncated membrane-free derivative of a membrane-bound protein
JPS615786A (ja) * 1984-06-19 1986-01-11 Chemo Sero Therapeut Res Inst 単純ヘルペスウイルス遺伝子を組込んだ組換えｄｎａ、形質転換動物細胞および単純ヘルペスウイルス蛋白質の製法
EP0170169B1 (en) * 1984-07-20 1991-03-20 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Recombinant dna containing a herpes simplex virus gene or a fragment thereof, yeast transformed with said recombinant dna, and method for the production of herpes simplex virus proteins
US4659568A (en) * 1985-02-27 1987-04-21 American Cyanamid Company Process for solubilization, purification and characterization of protein from insoluble protein aggregates or complexes and compositions of matter therefrom
DE3510734A1 (de) * 1985-03-25 1986-09-25 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung eines fuer herpes simplex virus typ 2 spezifischen antigens, dazu geeignetes mittel und verwendung dieses antigens
JPH0668B2 (ja) * 1985-08-30 1994-01-05 財団法人化学及血清療法研究所 単純ヘルペスウイルス遺伝子が組込まれた組換えプラスミド
EP0471778A1 (en) * 1989-05-12 1992-02-26 Ciba Corning Diagnostics Corp. Herpes simplex virus type 2-glycoprotein g proteins and polypeptides
US5149532A (en) * 1989-11-01 1992-09-22 Cedars Sinai Medical Center Method of vaccine or toxoid preparation and immunization by colonization with recombinant microorganisms
CA2538794C (en) 2003-09-12 2016-04-19 Antigenics, Inc. Vaccine for treatment and prevention of herpes simplex virus infection
US10918712B2 (en) 2014-03-03 2021-02-16 Albert Einstein College Of Medicine Passive transfer of immunity using recombinant herpes simplex virus 2 (HSV-2) vaccine vectors
CN110938604B (zh) * 2014-03-03 2024-04-05 阿尔伯特爱因斯坦医学院 重组单纯疱疹病毒2(hsv-2)疫苗载体

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3228501A1 (de) * 1982-07-30 1984-02-02 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung eines herpes-antigens, dazu geeignetes mittel sowie verfahren zu seiner herstellung und die verwendung dieses antigens

Also Published As

Publication number Publication date
GR78647B (da) 1984-09-27
PT77014A (en) 1983-08-01
IE831690L (en) 1984-01-20
PT77014B (en) 1986-01-24
EP0101655A2 (en) 1984-02-29
ES529225A0 (es) 1985-05-16
DK333183D0 (da) 1983-07-19
PL150654B1 (en) 1990-06-30
FI832632A0 (fi) 1983-07-19
FI83974C (fi) 1991-09-25
ES524245A0 (es) 1985-04-01
DE3382072D1 (de) 1991-02-07
ES8504254A1 (es) 1985-04-01
EP0101655B1 (en) 1991-01-02
PH21239A (en) 1987-08-21
ES8505253A1 (es) 1985-05-16
IE56902B1 (en) 1992-01-29
PL243134A1 (en) 1984-08-13
NO832626L (no) 1984-01-23
IL69269A0 (en) 1983-11-30
FI83974B (fi) 1991-06-14
FI832632A (fi) 1984-01-21
EP0101655A3 (en) 1985-12-18
NO172855B (no) 1993-06-07
IL69269A (en) 1989-12-15
CA1295561C (en) 1992-02-11
NO172855C (no) 1993-09-15
NZ204948A (en) 1987-10-30

Similar Documents

Publication Publication Date Title
DK1183A (da) Fremgangsmaade til fremstilling af tiazolidinderivater
DK29183D0 (da) Fremgangsmade til fremstilling af purinderivater
DK301383D0 (da) Fremgangsmade til fremstilling af imidazolderivater
DK333183A (da) Fremgangsmaade til fremstilling af herpes simplex virusglycoproteiner
DK241883D0 (da) Fremgangsmade til fremstilling af 1-sulfo-2-oxoazetidinderivater
DK372283D0 (da) Fremgangsmade til fremstilling af desoxyuridinderivater
DK309783A (da) Fremgangsmaade til fremstilling af organoglykosider
DK53483D0 (da) Fremgangsmade til fremstilling af guanidinderivater
DK119083D0 (da) Fremgangsmade til fremstilling af alkanoylpyridinoner
DK261883D0 (da) Fremgangsmade til fremstilling af prostaglandin-d-derivater
DK508983A (da) Fremgangsmaade til fremstilling af analgetisk virksomme peptidforbindelser
DK162230C (da) Fremgangsmaade til fremstilling af 2-thiacephemderivater
DK424083A (da) Fremgangsmaade til fremstilling af anthracyclinglycosider
DK165583D0 (da) Fremgangsmade til fremstilling af furanderivater
DK296383A (da) Fremgangsmaade til fremstilling af fenaetylaminer
DK273183D0 (da) Fremgangsmade til fremstilling af amidiner
DK152051C (da) Fremgangsmaade til fremstilling af krystallinsk natriumcefoperazon
DK219483A (da) Fremgangsmaade til fremstilling af anthracyclinglycosider
DK62283A (da) Fremgangsmaade til fremstilling af peptidergotalkaloider
DK104583D0 (da) Fremgangsmade til fremstilling af phospholipider
DK10883D0 (da) Fremgangsmade til fremstilling af substituerede chloracetanilider
DK164283D0 (da) Fremgangsmade til fremstilling af benzimidazolderivater
DK164044C (da) Saerlig fremgangsmaade til fremstilling af bischolindisulfonater
DK96383A (da) Fremgangsmaade til fremstilling af 3-azetidinylaetyl-1-fenyl-2-imidazolidinonderivater
DK66483A (da) Fremgangsmaade til fremstilling af ergotalkaloider